User profiles for Michele Morris

Michele Morris

- Verified email at med.miami.edu - Cited by 8065

michele morris

- Verified email at pitt.edu - Cited by 1705

The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment

…, L Lingrey, RT Miller, M Morris… - Journal of the …, 2021 - academic.oup.com
Objective Coronavirus disease 2019 (COVID-19) poses societal challenges that require
expeditious data and knowledge sharing. Though organizational clinical data are abundant, …

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

D Kumar, MG Michaels, MI Morris, M Green… - The Lancet infectious …, 2010 - thelancet.com
Background There are few data on the epidemiology and outcomes of influenza infection in
recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic …

Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US National COVID Cohort Collaborative

…, A Manna, JA McMurry, M Morris… - JAMA network …, 2021 - jamanetwork.com
Importance The National COVID Cohort Collaborative (N3C) is a centralized, harmonized,
high-granularity electronic health record repository that is the largest, most representative …

[HTML][HTML] Identifying who has long COVID in the USA: a machine learning approach using N3C data

…, MA Haendel, C Bramante, D Dorr, M Morris… - The Lancet Digital …, 2022 - thelancet.com
Background Post-acute sequelae of SARS-CoV-2 infection, known as long COVID, have
severely affected recovery from the COVID-19 pandemic for patients and society alike. Long …

The Deferasirox–AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial

…, DP Kontoyiannis, MI Morris… - Journal of …, 2012 - academic.oup.com
Objectives Host iron availability is fundamental to mucormycosis pathogenesis. The
combination of liposomal amphotericin B (LAmB) and deferasirox iron chelation therapy …

COVID-19 in solid organ transplant recipients: a systematic review and meta-analysis of current literature

…, G Guerra, JF Camargo, J Simkins, MI Morris… - Transplantation …, 2021 - Elsevier
Severe acute respiratory virus syndrome 2 (SARS-CoV-2) has led to a worldwide pandemic.
Early studies in solid organ transplant (SOT) recipients suggested a wide variety of …

Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a …

…, L Ely, DR Kaul, BS Schwartz, MI Morris… - Clinical infectious …, 2013 - academic.oup.com
Background. Cytomegalovirus (CMV) disease remains an important problem in solid-organ
transplant recipients, with the greatest risk among donor CMV-seropositive, recipient-…

The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement

…, P Ljungman, H Milburn, MI Morris… - European …, 2012 - Eur Respiratory Soc
Tuberculosis (TB) is a possible complication of solid organ and hematopoietic stem cell
transplantation. The identification of candidates for preventive chemotherapy is an effective …

[HTML][HTML] Screening and treatment of chagas disease in organ transplant recipients in the United States: recommendations from the chagas in transplant working group

…, SP Montgomery, S Kontak, B Kubak, MI Morris… - American journal of …, 2011 - Elsevier
Donor-derived transmission of Trypanosoma cruzi, the etiologic agent of Chagas disease,
has emerged as an issue in the United States over the past 10 years. Acute T. cruzi infection …

Varicella-zoster virus infections in patients treated with fingolimod: risk assessment and consensus recommendations for management

AM Arvin, JS Wolinsky, L Kappos, MI Morris… - JAMA …, 2015 - jamanetwork.com
Importance Varicella-zoster virus (VZV) infections increasingly are reported in patients with
multiple sclerosis (MS) and constitute an area of significant concern, especially with the …